ClinConnect ClinConnect Logo
Search / Trial NCT07007572

Evaluation Of Marginal Bone Height Changes And Biting Force In Screw Retained Implant Prostheses Using Reinforced Resin Vs Monolithic Zirconium

Launched by CAIRO UNIVERSITY · Jun 3, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Biting Forces Bacterial Adhesion Color Stability Soft Tissue Response Prosthetic Complication

ClinConnect Summary

This clinical trial is studying two different types of materials used in dental implants: a reinforced resin and a solid zirconia. The goal is to see how these materials affect the strength of biting and any changes in the bone around the implants. This research is important because it can help improve dental solutions for patients who need artificial teeth.

To be eligible for this trial, participants should be adults aged 30 to 60 who have specific dental conditions, such as missing teeth in the lower jaw but have healthy gums and bones. It's also essential that they can attend follow-up visits and are in good health overall. If someone has certain medical conditions, like Parkinson's disease or is a heavy smoker, they may not qualify. Participants can expect to receive dental implants and will be monitored over time to assess their progress and any changes related to the materials used. This study is currently looking for volunteers to join and contribute to improving dental health options.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Mandibular Class II, partially edentulous patients that enables measuring the marginal bone height changes and values of biting forces intra-orally.
  • Fully dentulous edentulous opposing Maxillary arch.
  • Patients with normal class I jaw relationship.
  • Patients that require fixed restorations for functional and esthetic reasons
  • Age range (30-60 years).
  • Cooperative patients those are willing to attend all follow-up periods.
  • Patients with healthy attached mucosa of appropriate thickness free from any inflammation.
  • Patients with healthy bone of appropriate thickness, width and height free from any inflammation.
  • Patients without any medical conditions that contraindicates implant placement.
  • Exclusion Criteria:
  • Patients with Parkinson's disease
  • Patients with xerostomia.
  • Patients with a history of allergy to resins and/ or zirconia.
  • Patients with a medical systematic condition that contraindicate implant placement.
  • Patients smoking more than 10 cigarettes per day.
  • Patients with pathological changes of residual ridges as recurrent or persistent ulcers, osteomyelitis and infections.
  • Patients with large irregular bony exostosis.
  • Patients with medical or psychological conditions as physical disability or mental retardation that hinder cooperation in the follow up visits and answering the questionnaires.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported